Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.

Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB, Bacchetta R, Tsalenko A, Dellinger D, Bruhn L, Porteus MH.

Nat Biotechnol. 2015 Sep;33(9):985-989. doi: 10.1038/nbt.3290. Epub 2015 Jun 29.

2.

ENViz: a Cytoscape App for integrated statistical analysis and visualization of sample-matched data with multiple data types.

Steinfeld I, Navon R, Creech ML, Yakhini Z, Tsalenko A.

Bioinformatics. 2015 May 15;31(10):1683-5. doi: 10.1093/bioinformatics/btu853. Epub 2015 Jan 9.

3.

Population-genetic properties of differentiated human copy-number polymorphisms.

Campbell CD, Sampas N, Tsalenko A, Sudmant PH, Kidd JM, Malig M, Vu TH, Vives L, Tsang P, Bruhn L, Eichler EE.

Am J Hum Genet. 2011 Mar 11;88(3):317-32. doi: 10.1016/j.ajhg.2011.02.004.

4.

Visualization of fine-scale genomic structure by oligonucleotide-based high-resolution FISH.

Yamada NA, Rector LS, Tsang P, Carr E, Scheffer A, Sederberg MC, Aston ME, Ach RA, Tsalenko A, Sampas N, Peter B, Bruhn L, Brothman AR.

Cytogenet Genome Res. 2011;132(4):248-54. doi: 10.1159/000322717. Epub 2010 Dec 18.

5.

Diversity of human copy number variation and multicopy genes.

Sudmant PH, Kitzman JO, Antonacci F, Alkan C, Malig M, Tsalenko A, Sampas N, Bruhn L, Shendure J; 1000 Genomes Project, Eichler EE.

Science. 2010 Oct 29;330(6004):641-6. doi: 10.1126/science.1197005.

6.

Characterization of missing human genome sequences and copy-number polymorphic insertions.

Kidd JM, Sampas N, Antonacci F, Graves T, Fulton R, Hayden HS, Alkan C, Malig M, Ventura M, Giannuzzi G, Kallicki J, Anderson P, Tsalenko A, Yamada NA, Tsang P, Kaul R, Wilson RK, Bruhn L, Eichler EE.

Nat Methods. 2010 May;7(5):365-71.

7.

SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance.

Edvardsen H, Brunsvig PF, Solvang H, Tsalenko A, Andersen A, Syvanen AC, Yakhini Z, Børresen-Dale AL, Olsen H, Aamdal S, Kristensen VN.

Pharmacogenomics J. 2010 Dec;10(6):513-23. doi: 10.1038/tpj.2010.6. Epub 2010 Feb 16.

PMID:
20157331
8.

Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types.

Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z.

PLoS One. 2009 Nov 25;4(11):e8003. doi: 10.1371/journal.pone.0008003.

9.

Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival.

Nordgard SH, Alnaes GI, Hihn B, Lingjaerde OC, Liestøl K, Tsalenko A, Sørlie T, Lønning PE, Børresen-Dale AL, Kristensen VN.

Int J Cancer. 2008 Aug 1;123(3):577-85. doi: 10.1002/ijc.23541.

10.

The fine-scale and complex architecture of human copy-number variation.

Perry GH, Ben-Dor A, Tsalenko A, Sampas N, Rodriguez-Revenga L, Tran CW, Scheffer A, Steinfeld I, Tsang P, Yamada NA, Park HS, Kim JI, Seo JS, Yakhini Z, Laderman S, Bruhn L, Lee C.

Am J Hum Genet. 2008 Mar;82(3):685-95. doi: 10.1016/j.ajhg.2007.12.010. Epub 2008 Jan 24.

11.

High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells.

Prasad M, Bernardini M, Tsalenko A, Marrano P, Paderova J, Lee CH, Ben-Dor A, Barrett MT, Squire JA.

Genes Chromosomes Cancer. 2008 May;47(5):427-36. doi: 10.1002/gcc.20547.

PMID:
18273836
12.

Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma.

Sun H, Chua MS, Yang D, Tsalenko A, Peter BJ, So S.

Biomark Insights. 2008 Jan 21;3:1-18.

13.

Benign copy number changes in clinical cytogenetic diagnostics by array CGH.

Whitby H, Tsalenko A, Aston E, Tsang P, Mitchell S, Bayrak-Toydemir P, Hopkins C, Peters G, Bailey DK, Bruhn L, Brothman AR.

Cytogenet Genome Res. 2008;123(1-4):94-101. doi: 10.1159/000184696. Epub 2009 Mar 11.

14.

Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases.

de Smith AJ, Tsalenko A, Sampas N, Scheffer A, Yamada NA, Tsang P, Ben-Dor A, Yakhini Z, Ellis RJ, Bruhn L, Laderman S, Froguel P, Blakemore AI.

Hum Mol Genet. 2007 Dec 1;16(23):2783-94. Epub 2007 Jul 31.

PMID:
17666407
15.

High resolution oligonucleotide CGH using DNA from archived prostate tissue.

Paris PL, Sridharan S, Scheffer A, Tsalenko A, Bruhn L, Collins C.

Prostate. 2007 Sep 15;67(13):1447-55.

16.

Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools.

Ach RA, Floore A, Curry B, Lazar V, Glas AM, Pover R, Tsalenko A, Ripoche H, Cardoso F, d'Assignies MS, Bruhn L, Van't Veer LJ.

BMC Genomics. 2007 Jun 7;8:148.

17.

A supervised approach for identifying discriminating genotype patterns and its application to breast cancer data.

Yosef N, Yakhini Z, Tsalenko A, Kristensen V, Børresen-Dale AL, Ruppin E, Sharan R.

Bioinformatics. 2007 Jan 15;23(2):e91-8.

PMID:
17237111
18.

Network analysis of human in-stent restenosis.

Ashley EA, Ferrara R, King JY, Vailaya A, Kuchinsky A, He X, Byers B, Gerckens U, Oblin S, Tsalenko A, Soito A, Spin JM, Tabibiazar R, Connolly AJ, Simpson JB, Grube E, Quertermous T.

Circulation. 2006 Dec 12;114(24):2644-54. Epub 2006 Dec 4.

19.

Analysis of SNP-expression association matrices.

Tsalenko A, Sharan R, Kristensen V, Edvardsen H, Børresen-Dale AL, Ben-Dor A, Yakhini Z.

J Bioinform Comput Biol. 2006 Apr;4(2):259-74.

PMID:
16819783
20.

Genetic variation in putative regulatory loci controlling gene expression in breast cancer.

Kristensen VN, Edvardsen H, Tsalenko A, Nordgard SH, Sørlie T, Sharan R, Vailaya A, Ben-Dor A, Lønning PE, Lien S, Omholt S, Syvänen AC, Yakhini Z, Børresen-Dale AL.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7735-40. Epub 2006 May 9.

Supplemental Content

Loading ...
Support Center